Related references
Note: Only part of the references are listed.Synthesis and cytotoxic activity of chalcone analogues containing a thieno [2,3-d]pyrimidin-2-yl group as the A-ring or B-ring
Fu-Cheng Wang et al.
BIOORGANIC CHEMISTRY (2020)
Recent developments of chalcones as potential antibacterial agents in medicinal chemistry
Wenjia Dan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review
Hua-Li Qin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
Shi Wei et al.
CELL DEATH & DISEASE (2020)
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases
Perihan A. Elzahhar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis, 18F-radiolabeling & galectin-1 inhibition studies
Nerella Sridhar Goud et al.
BIOORGANIC CHEMISTRY (2020)
Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches
Ahmed Karam Farag et al.
BIOORGANIC CHEMISTRY (2020)
Socio-economic inequalities in lung cancer incidence in Canada, 1992-2010: results from the Canadian Cancer Registry
M. Hajizadeh et al.
PUBLIC HEALTH (2020)
被撤回的出版物: Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma (Retracted article. See JUN, 2023)
Jing Meng et al.
ONCOGENE (2019)
Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs
Guo-qing Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors
Dong-Jun Fu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Zhi Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity
Patricia Pinto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of novel pyrazoloo-xothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549
S. Yakaiah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
The synthetic chalcone derivative 2-hydroxy-3′,5,5′-trimethoxychalcone induces unfolded protein response-mediated apoptosis in A549 lung cancer cells
Ha-Na Gil et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells
Huong Thuy Le et al.
CANCER LETTERS (2018)
Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity
Maliheh Safavi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells
Qun Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents
Muralidhar Allam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Design, synthesis, and evaluation of chalcone analogues incorporate alpha,beta-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis
Min Zhu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Chalcone: A Privileged Structure in Medicinal Chemistry
Chunlin Zhuang et al.
CHEMICAL REVIEWS (2017)
Heat Shock Protein 90 Inhibition in Cancer Drug Discovery: From Chemistry to Futural Clinical Applications
Aykut Ozgur et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Therapeutic potential of chalcones as cardiovascular agents
Debarshi Kar Mahapatra et al.
LIFE SCIENCES (2016)
Heat shock protein 90 inhibitors in non-small-cell lung cancer
Rathi N. Pillai et al.
CURRENT OPINION IN ONCOLOGY (2014)
Synthesis and Structure-Activity Relationship Studies of N-Benzyl-2-phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer
Thomas S. Dexheimer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog
Janel K. Warmka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yanke Yu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Synthesis of Imidazothiazole-Chalcone Derivatives as Anticancer and Apoptosis Inducing Agents
Ahmed Kamal et al.
CHEMMEDCHEM (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents
Jin Tatsuzaki et al.
JOURNAL OF NATURAL PRODUCTS (2006)
The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines
JW Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
